Pharmacovigilance Programme of India: A Review

Saurabh Nimesh; Surabhi Gupta; Kapil Dev Negi

Authors

Saurabh Nimesh
Surabhi Gupta
Kapil Dev Negi

Keywords:

vigiflow, UMC, death, thalidomide, reporting form, phocomelia

Abstract

In India, a proper adverse drug reaction monitoring system was started in 1986 with 12 regional centers. In 1997, India became the member of the World health organization Programme for International Drug watching managed by the Upsala Monitoring Centre, Sweden. At origination, 6 regional centers were created in Mumbai, New Delhi, Kolkata, Lucknow, Pondicherry, and Chandigarh for ADR watching within the country. Promoting safe use of drugs may be a priority of the Indian Pharmacopoeia Commission that functions as the National Coordination Centre for Pharmacovigilance Programme of India. Today, 179 adverse drug reactions monitoring centers presently report adverse events to the National coordinative centre in India.

Downloads

How to Cite

Pharmacovigilance Programme of India: A Review. (2020). Global Journal of Medical Research, 19(B3), 9-17. https://medicalresearchjournal.org/index.php/GJMR/article/view/1909

Download Citation

References

S Nimesh, Prem Parkash, K (2019) A Prospective Observational Study on Assessment of Adverse Drug Reactions in Patients taking First Line Antitubercular Drugs at Tertiary Care Teaching Hospital, Nellore. 7(1), 1-6.

S Nimesh, V Ashwlayan (2018) Pharmacovigilance: An Overview. 3(1), 1-6.

Nisha Kaushik, Arti Thakkar, K Bangarurajan (2006) COVID-19 and Standardized Vaccines Development: A Brief Review. 23(05), 325-343.

U (2017) National Library of Medicine. 3334-3345.

S Srivastava (2017) The Complete Cookery Book for Diabetics. 1(23), 888-889.

B Mohamed, I Elnagar (2017) Prevalence and Extent of Adverse Drug Reactions in Sudanese Patients in Highly Active Antiretroviral Therapy Regimens. 2(2), 1-12.

Z Zhu, B Hofauer, M Wirth, Katrin Hasselbacher, Helmut Frohnhofen, Clemens Heiser (2018) Selective upper airway stimulation in older patients. 140, 77-81.

S Najafi (2018) Importance of Pharmacovigilance and the Role of Healthcare Professionals. 6(1), 1-2.

(2018) Pharmacovigilance Programme of India. Safety of medicines: The journey travelled and the way forward. 32, 11-17.

Philip Routledge (2018) 150 years of pharmacovigilance. 351(9110), 1200-1201.

(2017) Role of Pharmacovigilance Programme of India (PvPI) in Adverse Drug Event Monitoring for medication safety in patient. 7(1).

Gurumurthy Parthasarathi, A Harugeri, K Undela (2018) Pharmacovigilance Research in India: A Five-Year Literature Review. 95(0), 225-232.

M Khan, S Ali, S Alam (2018) Assessment of prescribing trend of drugs at out patient's chest ward of government tertiary care hospital situated in karachi. 10(1), 1-4.

Francine Birungi, Stephen Graham, Jeannine Uwimana, Brian Van Wyk (2018) Assessment of the Isoniazid Preventive Therapy Uptake and Associated Characteristics: A Cross-Sectional Study. 2018, 1-9.

Vivekanandan Kalaiselvan, Prasad Thota, Gyanendranath Singh (2016) Pharmacovigilance Programme of India: Recent developments and future perspectives. 48(6), 624.

K Bester, H Meyer, M Crowther, R Gray (2018) Anaesthesia for paediatric patients: Minimising the risk. 108(6), 457-459.

C Krishnamurti (2018) Reprieves before rejection: chloroform for anesthesia. 7(3), 1-12.

J West (2018) The Accidental Poison That Founded the Modern FDA. Elixir Sulfanilamide was a breakthrough antibiotic-until it killed more than 100 people.

Knm Singh, H Kanase (2017) Pharmacovigilance Programme of India: The Beginning, Current Status and Recent Progress. 6(4), 1-3.

B Panja, S Bhowmick, V Chowrasia, S Bhattacharya, A Chatterjee R N, Sen (2015) A cross-sectional study of adverse drug reactions reporting among doctors of a private medical college in Bihar. 47(1), 126-127.

Helen Ndagije, Victoria Nambasa, Elizabeth Namagala, Huldah Nassali, Dan Kajungu, Gordon Sematiko, Sten Olsson, Shanthi Pal (2015) Targeted Spontaneous Reporting of Suspected Renal Toxicity in Patients Undergoing Highly Active Anti-Retroviral Therapy in Two Public Health Facilities in Uganda. 38(4), 395-408.

R Magazine, H A Shahul, B Chogtu, A Kamath (2016) Comparison of oral montelukast with oral zileuton in acute asthma: A randomized, double-blind, placebo-controlled study. 33(3), 281-286.

D Lal, S Manocha, Ray Vijayan V K, R Kumar (2015) Comparative study of the efficacy and safety of the ophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease. 26(5), 443-451.

H B Lande, S Kamble, M Pawar, S C Mohapatra (2016) Newer initiatives under rntcp. 3(1), 13-17.